SIGA Announces Oct. 12 Record Date for Rights Offering Read more about SIGA Announces Oct. 12 Record Date for Rights Offering SIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will Pay PharmAthene Claim in Full Read more about SIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will Pay PharmAthene Claim in Full SIGA Announces Completion of Enrollment and Dosing in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) Read more about SIGA Announces Completion of Enrollment and Dosing in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) SIGA Announces Data Safety Monitoring Board (DSMB) Approval to Complete Subject Enrollment in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) Read more about SIGA Announces Data Safety Monitoring Board (DSMB) Approval to Complete Subject Enrollment in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) SIGA Announces Enrollment of First Patients in the Final Cohort of Phase III Study of Tecovirimat Read more about SIGA Announces Enrollment of First Patients in the Final Cohort of Phase III Study of Tecovirimat SIGA Emerges from Chapter 11 Bankruptcy Protection Read more about SIGA Emerges from Chapter 11 Bankruptcy Protection SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX Read more about SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX SIGA Technologies Engages PiperJaffray as Financial Advisor Read more about SIGA Technologies Engages PiperJaffray as Financial Advisor FDA Concurs on Clinical Dose for SIGA's Tecovirimat Antiviral Read more about FDA Concurs on Clinical Dose for SIGA's Tecovirimat Antiviral SIGA Files Consensual Plan of Reorganization Read more about SIGA Files Consensual Plan of Reorganization Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page Next › Last page Last » Subscribe to
SIGA Announces Oct. 12 Record Date for Rights Offering Read more about SIGA Announces Oct. 12 Record Date for Rights Offering
SIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will Pay PharmAthene Claim in Full Read more about SIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will Pay PharmAthene Claim in Full
SIGA Announces Completion of Enrollment and Dosing in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) Read more about SIGA Announces Completion of Enrollment and Dosing in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat)
SIGA Announces Data Safety Monitoring Board (DSMB) Approval to Complete Subject Enrollment in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat) Read more about SIGA Announces Data Safety Monitoring Board (DSMB) Approval to Complete Subject Enrollment in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat)
SIGA Announces Enrollment of First Patients in the Final Cohort of Phase III Study of Tecovirimat Read more about SIGA Announces Enrollment of First Patients in the Final Cohort of Phase III Study of Tecovirimat
SIGA Emerges from Chapter 11 Bankruptcy Protection Read more about SIGA Emerges from Chapter 11 Bankruptcy Protection
SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX Read more about SIGA Commences Clinical Study for Intravenous (IV) Formulation of TPOXX
SIGA Technologies Engages PiperJaffray as Financial Advisor Read more about SIGA Technologies Engages PiperJaffray as Financial Advisor
FDA Concurs on Clinical Dose for SIGA's Tecovirimat Antiviral Read more about FDA Concurs on Clinical Dose for SIGA's Tecovirimat Antiviral
SIGA Files Consensual Plan of Reorganization Read more about SIGA Files Consensual Plan of Reorganization